Alan J Russell is Chief Scientific Officer of Edgewise Therapeutics, Inc.. Currently has a direct ownership of 12,719 shares of EWTX, which is worth approximately $432,446. The most recent transaction as insider was on Sep 20, 2024, when has been sold 75,000 shares (Common Stock) at a price of $28.88 per share, resulting in proceeds of $2,166,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.7K
75.73% 3M change
92.78% 12M change
Total Value Held $432,446

Alan J Russell Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 20 2024
SELL
Open market or private sale
$2,166,000 $28.88 p/Share
75,000 Reduced 85.5%
12,719 Common Stock
Sep 20 2024
BUY
Exercise of conversion of derivative security
$13,500 $0.18 p/Share
75,000 Added 46.09%
87,719 Common Stock
May 02 2024
SELL
Open market or private sale
$29,802 $18.91 p/Share
1,576 Reduced 17.88%
7,238 Common Stock
May 01 2024
BUY
Exercise of conversion of derivative security
-
5,208 Added 37.14%
8,814 Common Stock
Dec 26 2023
SELL
Open market or private sale
$1,610,218 $9.33 p/Share
172,585 Reduced 97.95%
3,606 Common Stock
May 02 2023
SELL
Open market or private sale
$14,257 $8.9 p/Share
1,602 Reduced 0.9%
176,191 Common Stock
May 01 2023
BUY
Exercise of conversion of derivative security
-
5,208 Added 2.85%
177,793 Common Stock
Nov 30 2021
BUY
Exercise of conversion of derivative security
$55,227 $0.32 p/Share
172,585 Added 50.0%
172,585 Common Stock
Nov 15 2021
SELL
Open market or private sale
$9,264 $19.34 p/Share
479 Reduced 100.0%
0 Common Stock
Nov 12 2021
SELL
Open market or private sale
$167,045 $19.51 p/Share
8,562 Reduced 94.7%
479 Common Stock
Nov 11 2021
SELL
Open market or private sale
$388,026 $20.13 p/Share
19,276 Reduced 68.07%
9,041 Common Stock
Nov 10 2021
SELL
Open market or private sale
$246,027 $19.96 p/Share
12,326 Reduced 30.33%
28,317 Common Stock
Nov 09 2021
SELL
Open market or private sale
$595,069 $20.12 p/Share
29,576 Reduced 42.12%
40,643 Common Stock
Nov 08 2021
SELL
Open market or private sale
$181,783 $20.16 p/Share
9,017 Reduced 11.38%
70,219 Common Stock
Nov 05 2021
SELL
Open market or private sale
$262,927 $20.16 p/Share
13,042 Reduced 14.13%
79,236 Common Stock
Nov 04 2021
SELL
Open market or private sale
$146,066 $19.76 p/Share
7,392 Reduced 7.42%
92,278 Common Stock
Nov 03 2021
SELL
Open market or private sale
$490,950 $18.75 p/Share
26,184 Reduced 20.81%
99,670 Common Stock
Nov 02 2021
SELL
Open market or private sale
$305,356 $17.43 p/Share
17,519 Reduced 12.22%
125,854 Common Stock
Nov 01 2021
SELL
Open market or private sale
$8,451 $18.02 p/Share
469 Reduced 0.33%
143,373 Common Stock
Oct 15 2021
SELL
Open market or private sale
$25,894 $18.07 p/Share
1,433 Reduced 0.99%
143,842 Common Stock
Oct 14 2021
SELL
Open market or private sale
$104,517 $18.18 p/Share
5,749 Reduced 3.81%
145,275 Common Stock
Oct 11 2021
SELL
Open market or private sale
$22,885 $18.02 p/Share
1,270 Reduced 0.83%
151,024 Common Stock
Oct 08 2021
SELL
Open market or private sale
$107,121 $18.15 p/Share
5,902 Reduced 3.73%
152,294 Common Stock
Oct 07 2021
SELL
Open market or private sale
$241,614 $18.56 p/Share
13,018 Reduced 7.6%
158,196 Common Stock
Oct 06 2021
SELL
Open market or private sale
$38,007 $18.03 p/Share
2,108 Reduced 1.22%
171,214 Common Stock
AJR

Alan J Russell

Chief Scientific Officer
Boulder, CO

Track Institutional and Insider Activities on EWTX

Follow Edgewise Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EWTX shares.

Notify only if

Insider Trading

Get notified when an Edgewise Therapeutics, Inc. insider buys or sells EWTX shares.

Notify only if

News

Receive news related to Edgewise Therapeutics, Inc.

Track Activities on EWTX